Login / Signup
Dupilumab in atopic dermatitis, a protocol for SARS-COV-2-infected patients.
Maria Fernanda Ordóñez Rubiano
Isabela Campo
Mirian Casas
Published in:
Dermatologic therapy (2020)
Keyphrases
</>
atopic dermatitis
sars cov
respiratory syndrome coronavirus
randomized controlled trial